Juliette Gafni

3.3k total citations · 1 hit paper
19 papers, 2.7k citations indexed

About

Juliette Gafni is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Juliette Gafni has authored 19 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Juliette Gafni's work include Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Hereditary Neurological Disorders (4 papers). Juliette Gafni is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Hereditary Neurological Disorders (4 papers). Juliette Gafni collaborates with scholars based in United States, Canada and France. Juliette Gafni's co-authors include Lisa Ellerby, Michelle C. Catlin, Tadeusz F. Molinski, Lucio G. Costa, Isaac N. Pessah, Cheryl L. Wellington, Michael R. Hayden, Evan Hermel, Jessica E. Young and Christopher A. Ross and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Juliette Gafni

19 papers receiving 2.6k citations

Hit Papers

Xestospongins: Potent Membrane Permeable Blockers of the ... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juliette Gafni United States 19 1.9k 1.7k 483 357 221 19 2.7k
Srinivasa Subramaniam United States 27 1.3k 0.7× 942 0.6× 332 0.7× 266 0.7× 327 1.5× 44 2.2k
Mathieu Lesort United States 31 1.3k 0.6× 1.2k 0.7× 646 1.3× 321 0.9× 681 3.1× 53 2.8k
Vilen Movsesyan United States 22 1.1k 0.6× 756 0.4× 293 0.6× 148 0.4× 238 1.1× 27 2.0k
Mariaelena Repici Italy 19 924 0.5× 629 0.4× 287 0.6× 170 0.5× 336 1.5× 37 1.9k
Maureen W. McEnery United States 25 2.1k 1.1× 1.5k 0.9× 147 0.3× 137 0.4× 289 1.3× 38 2.8k
Simonetta Sipione Canada 30 3.0k 1.5× 2.3k 1.4× 775 1.6× 402 1.1× 544 2.5× 51 4.2k
Douglas B. Kintner United States 27 1.1k 0.6× 944 0.6× 183 0.4× 159 0.4× 233 1.1× 53 2.1k
Isao Nishimura Japan 17 953 0.5× 548 0.3× 422 0.9× 270 0.8× 545 2.5× 25 1.7k
Marianna Storto Italy 29 1.2k 0.6× 1.3k 0.7× 214 0.4× 83 0.2× 457 2.1× 60 2.5k
Pascal Dournaud France 27 1.1k 0.6× 909 0.5× 231 0.5× 130 0.4× 311 1.4× 58 2.5k

Countries citing papers authored by Juliette Gafni

Since Specialization
Citations

This map shows the geographic impact of Juliette Gafni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliette Gafni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliette Gafni more than expected).

Fields of papers citing papers by Juliette Gafni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliette Gafni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliette Gafni. The network helps show where Juliette Gafni may publish in the future.

Co-authorship network of co-authors of Juliette Gafni

This figure shows the co-authorship network connecting the top 25 collaborators of Juliette Gafni. A scholar is included among the top collaborators of Juliette Gafni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliette Gafni. Juliette Gafni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gafni, Juliette, Jennifer Holcomb, Sylvia Chen, et al.. (2012). Caspase-6 Activity in a BACHD Mouse Modulates Steady-State Levels of Mutant Huntingtin Protein But Is Not Necessary for Production of a 586 Amino Acid Proteolytic Fragment. Journal of Neuroscience. 32(22). 7454–7465. 36 indexed citations
2.
Miller, John P., Bridget Yates, Ismael Al‐Ramahi, et al.. (2012). A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease. PLoS Genetics. 8(11). e1003042–e1003042. 35 indexed citations
3.
Leyva, Melissa J., Linda S. Kaltenbach, Jennifer Holcomb, et al.. (2010). Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington's Disease Models. Chemistry & Biology. 17(11). 1189–1200. 42 indexed citations
4.
Landles, Christian, Kirupa Sathasivam, Andreas Weiss, et al.. (2010). Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease. Journal of Biological Chemistry. 285(12). 8808–8823. 258 indexed citations
5.
Miller, John P., Jennifer Holcomb, Ismael Al‐Ramahi, et al.. (2010). Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease. Neuron. 67(2). 199–212. 136 indexed citations
6.
Gafni, Juliette, Xin Cong, Sylvia F. Chen, Bradford W. Gibson, & Lisa Ellerby. (2009). Calpain-1 Cleaves and Activates Caspase-7. Journal of Biological Chemistry. 284(37). 25441–25449. 57 indexed citations
7.
Schilling, Birgit, Juliette Gafni, Xin Cong, et al.. (2006). Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry. Journal of Biological Chemistry. 281(33). 23686–23697. 115 indexed citations
8.
Jin, Kunlin, Michelle LaFevre-Bernt, Yunjuan Sun, et al.. (2005). FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proceedings of the National Academy of Sciences. 102(50). 18189–18194. 168 indexed citations
9.
Tanaka, Yuji, Shuichi Igarashi, Masayuki Nakamura, et al.. (2005). Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiology of Disease. 21(2). 381–391. 56 indexed citations
10.
Hermel, Evan, Juliette Gafni, Stephanie Propp, et al.. (2004). Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death and Differentiation. 11(4). 424–438. 168 indexed citations
11.
Gafni, Juliette, Evan Hermel, Jessica E. Young, et al.. (2004). Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity. Journal of Biological Chemistry. 279(19). 20211–20220. 226 indexed citations
13.
Gafni, Juliette & Lisa Ellerby. (2002). Calpain Activation in Huntington's Disease. Journal of Neuroscience. 22(12). 4842–4849. 254 indexed citations
14.
Wellington, Cheryl L., Lisa Ellerby, Claire‐Anne Gutekunst, et al.. (2002). Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease. Journal of Neuroscience. 22(18). 7862–7872. 303 indexed citations
15.
Gafni, Juliette, et al.. (1997). Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor. Neuron. 19(3). 723–733. 525 indexed citations breakdown →
16.
Cj, Epstein, et al.. (1996). Neuroprotective role of CuZn-superoxide dismutase in ischemic brain damage.. PubMed. 71. 271–280. 22 indexed citations
17.
Chan, Pak H., C. J. Epstein, Hiroyuki Kinouchi, et al.. (1994). SOD‐1 Transgenic Mice as a Model for Studies of Neuroprotection in Stroke and Brain Traumaa. Annals of the New York Academy of Sciences. 738(1). 93–103. 34 indexed citations
18.
Karibe, Hiroshi, Sylvia F. Chen, Gregory J. Zarow, et al.. (1994). Mild intraischemic hypothermia suppresses consumption of endogenous antioxidants after temporary focal ischemia in rats. Brain Research. 649(1-2). 12–18. 84 indexed citations
19.
Chan, Pak H., et al.. (1993). Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 5(3). 293–296. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026